{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:40:50Z","timestamp":1756384850571},"reference-count":36,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5551\/jat.10819","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T03:55:45Z","timestamp":1333511745000},"page":"471-478","source":"Crossref","is-referenced-by-count":20,"title":["A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients"],"prefix":"10.5551","volume":"19","author":[{"given":"Cristiana","family":"Catena","sequence":"first","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medicine, University of Udine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GianLuca","family":"Colussi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medicine, University of Udine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Brosolo","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medicine, University of Udine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo A","family":"Sechi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medicine, University of Udine."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Simon A, Megnien JL, Levenson J: Coronary risk estimation and treatment of hypercolesterolemia. Circulation, 1997; 96: 2449-2452","DOI":"10.1161\/01.CIR.96.7.2449"},{"key":"2","unstructured":"2) Aminbakhsh A, Mancini GB: Carotid intima-media thickness measurement: what defines an abnormality? A systematic review. Clin Invest Med, 1999; 22: 149-157"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Irie Y, Sakamoto K, Kubo F, Okusu T, Katura T, Yamamoto Y, Umayahara Y, Katakami N, Kaneto H, Kashiyama T, Ueda Y, Kosugi K: Association of coronary artery stenosis with carotid atherosclerosis in asymptomatic type 2 diabetic patients. J Atheroscler Thromb, 2011; 18(4): 337-344","DOI":"10.5551\/jat.6049"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J: Risk factors for and the prevalence of peripheral arterial disease and its relatiomship to carotid atherosclerosis: the Kyushu and Okinawa population Study (KOPS). J Atheroscler Thromb, 2010; 17: 751-758","DOI":"10.5551\/jat.3731"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kablak-Ziembicka A, Przewlocki T, Sokolowski A, Tracz W, Podolec P: Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis, 2011; 214: 185-190","DOI":"10.1016\/j.atherosclerosis.2010.10.017"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC): 2007 Guidelines for the management of arterial hypertension. J Hypertens, 2007; 25: 1105-1187","DOI":"10.1097\/HJH.0b013e3281fc975a"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J: Intima-media thickness: new tool for diagnosis and treatment of cardiovascular (a ) risk. J Hypertens, 2002; 20: 159-169","DOI":"10.1097\/00004872-200202000-00001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Catena C, Novello M, Lapenna R, Baroselli S, Colussi GL, Nadalini E, Favret G, Cavarape A, Soardo G, Sechi LA: New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens, 2005; 23: 1617-1631","DOI":"10.1097\/01.hjh.0000178835.33976.e7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Folsom AR: Hemostatic risk factors for atherosclerotic disease: an epidemiologic view. Thromb Haemost, 2001; 86: 366-373","DOI":"10.1055\/s-0037-1616234"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Koenig W: Fibrinogen in cardiovascular disease: an update. Thromb Haemost, 2003; 89: 601-609","DOI":"10.1055\/s-0037-1613566"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ: Plasma concentrations of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation, 1994; 90: 2236-2240","DOI":"10.1161\/01.CIR.90.5.2236"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, Tracy RP: Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 1999; 19: 493-498","DOI":"10.1161\/01.ATV.19.3.493"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S: Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension, 2000; 36: 978-985","DOI":"10.1161\/01.HYP.36.6.978"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Paramo JA, Orbe J, Beloqui O, Benito A, Colina I, Martinez-Vila E, Diez J: Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Stroke, 2004; 35: 1085- 1089","DOI":"10.1161\/01.STR.0000124927.38723.f2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E: Association of serum lipoprotein(a) and size apolipoprotein(a) polimorphism with target-organ damage in arterial hypertension. JAMA, 1997; 277: 1689-1695","DOI":"10.1001\/jama.1997.03540450045033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Stein JH, Korcarz CE, Todd Hurst R, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS: Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr, 2008; 21: 93-111","DOI":"10.1016\/j.echo.2007.11.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Friedewald WT, Levi RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem, 1972; 18: 499-502","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Rossi E, Mondonico P, Lombardi A, Preda L: Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res, 1988; 52: 453-468","DOI":"10.1016\/0049-3848(88)90029-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost, 1991; 65: 153-159","DOI":"10.1055\/s-0038-1647475"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ: An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res, 1983; 31: 767-778","DOI":"10.1016\/0049-3848(83)90108-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S: Abnormalities of glucose metabolism in patients with early renal failure. Diabetes, 2002; 51: 1226-1232","DOI":"10.2337\/diabetes.51.4.1226"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Salomaa V, Stinson JD, Kark JD, Folsom AR, Davis CE, Wu KK: Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Circulation, 1995; 91: 284-290","DOI":"10.1161\/01.CIR.91.2.284"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) De Maat MDM, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J: Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost, 2003; 1: 950-957","DOI":"10.1046\/j.1538-7836.2003.00213.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lee AJ, Mowbray PI, Lowe GDO, Rumley A, Fowkes GR, Allan PL: Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh Artery Study. Circulation, 1998; 97: 1467-1473","DOI":"10.1161\/01.CIR.97.15.1467"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Grebe MT, Luu B, Sedding D, Heidt MC, Kemkes-Matthes B, Schaefer CA, Tllmans HH, Gunduz D: Fibrinogen promotes early atherosclerotic changes of the carotid artery in young, healthy adults. J Atheroscler Thromb, 2010; 17: 1003-1008","DOI":"10.5551\/jat.3715"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Corrado E, Rizzo M, Muratori I, Coppola G, Novo S: Association of elevated fibrinogen C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res, 2006; 37: 1004-1009","DOI":"10.1016\/j.arcmed.2006.06.005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Brzosko S, Hryszko T, Lebkowska U, Malyszko JS, Mysliwiec M: Plasma tissue-type plasminogen activator, fibrinogen, and time on dialysis prior to transplantation are related to carotid intima-media thickness in renal transplant recipients. Transplant Proc, 2003; 35: 2931-2934","DOI":"10.1016\/j.transproceed.2003.10.089"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Faintuch J, Marques PC, Bortolotto LA, Faintuch JJ, Cecconello I: Systemic inflammation and cardiovascular risk factors: are morbidly obese subjects different? Obes Surg, 2008; 18: 854-862","DOI":"10.1007\/s11695-008-9504-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Haiashy S: Significance of plasma D-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness. Int J Hematol, 2010; 92: 76-82","DOI":"10.1007\/s12185-010-0622-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Meade TW, Mellows S, Brozovic M: Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet, 1986; ii: 533-537","DOI":"10.1016\/S0140-6736(86)90111-X"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wilhelmsen L, Svardsudd K, Koran-Bengtsen K, Larsson B, Weilin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med, 1984; 11: 501-505","DOI":"10.1056\/NEJM198408233110804"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ: Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int Epidemiol, 1991; 20: 384-392","DOI":"10.1093\/ije\/20.2.384"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Koenig W, Ernst E: Fibrinogen and atherothrombogenesis. Curr Opin Lipidol, 1993; 4: 471-476","DOI":"10.1097\/00041433-199312000-00008"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Graeff H, Hafter R: Detection and relevance of cross linked fibrin derivates in blood. Semin Thromb Haemost, 1982; 8: 57-68","DOI":"10.1055\/s-2007-1005042"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol, 1997; 17: 3321-3325","DOI":"10.1161\/01.ATV.17.11.3321"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fowkes SG, Lowe GD, Housley E, Rattray A, Elton RA: Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet, 1993; 342: 84-86","DOI":"10.1016\/0140-6736(93)91288-W"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/5\/19_10819\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T10:48:44Z","timestamp":1593946124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/5\/19_10819\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.10819","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}